Draupnir Bio
Casper Larsen has a diverse work experience in the field of molecular biology and genetics. Casper started their career as a research assistant at Health - Aarhus University in 2014. In 2017, they joined Molecular Biology & Genetics - Aarhus University as a Postdoctoral Research Fellow. Casper worked in this role until September 2020. Currently, Casper is employed as a Senior Scientist at Draupnir Bio, where they have been working since September 2020.
Casper Larsen pursued their education at Aarhus University, Denmark. Casper started their academic journey in 2009 and completed their Bachelor of Science (BSc) degree in Molecular Biology in 2012. Casper then furthered their studies at Aarhus University and obtained their Master of Science (MSc) degree in Molecular Biology in 2014. Casper Larsen continued their education at the same institution and successfully completed their Doctor of Philosophy (PhD) degree in Structural Biology in 2017.
This person is not in any teams
Draupnir Bio
Draupnir Bio intends to develop a new type of cholesterol-lowering medicine that prevents blood clots in the heart more effectively than the current medicine. The company is developing a platform for exploring the glycome to develop novel therapeutics, based on array technology, protein chemistry, and advanced carbohydrate chemistry. The company isable to synthesize, screen, and select highly potent and specific heparan sulfate glycomimetic drug candidates in cardiovascular, inflammatory, and infectious diseases.